Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FlexSite targets diabetes in self-collect strategy:

This article was originally published in Clinica

Executive Summary

FlexSite Diagnostics is to launch KidneyScreen At Home, a self-test kit for microalbuminaria analysis in diagnosed diabetics. The kit allows for users to mail back the sample in a desiccated state, allowing for early detection of nephropathy, a condition emanating from diabetes, which is highly treatable in its early stages. The test is ordered over the Internet and the sample is mailed to FlexSite's laboratory for analysis. The product joins FlexSite's A1c At Home, a glycated haemoglobin test for longterm diabetes management.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel